Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker of severity. The aim of this study was to evaluate whether galectin-3 is associated with thrombogenicity in COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Puccini, Marianna, Jakobs, Kai, Reinshagen, Leander, Friebel, Julian, Schencke, Philipp-Alexander, Ghanbari, Emily, Landmesser, Ulf, Haghikia, Arash, Kränkel, Nicolle, Rauch, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178107/
https://www.ncbi.nlm.nih.gov/pubmed/37175392
http://dx.doi.org/10.3390/ijms24097683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178107/
https://www.ncbi.nlm.nih.gov/pubmed/37175392
http://dx.doi.org/10.3390/ijms24097683

Ejemplares similares